Kamada Ltd.
A biopharmaceutical company specializing in plasma-derived protein therapeutics.
KMDA | TA
Overview
Corporate Details
- ISIN(s):
- IL0010941198
- LEI:
- Country:
- Israel
- Address:
- 2 Holzman St, Science Park, 7670402 Rehovot
- Website:
- https://www.kamada.com
- Sector:
- Manufacturing
Description
Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-11-04 15:18 |
NOTICE OF 2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS
|
English | 200.8 KB | ||
| 2021-11-04 15:18 |
NOTICE OF 2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS
|
English | 163.0 KB | ||
| 2021-11-04 15:01 |
Annual General Meeting to be held on December 16, 2021
|
English | 374.1 KB | ||
| 2021-11-04 15:01 |
Annual General Meeting to be held on December 16, 2021
|
English | 35.9 KB | ||
| 2021-08-11 16:01 |
Reports Second Quarter and First Half 2021 Financial Results
|
English | 274.2 KB | ||
| 2021-08-11 16:01 |
Reports Second Quarter and First Half 2021 Financial Results
|
English | 36.2 KB | ||
| 2021-08-05 16:04 |
Kamada to Announce Second Quarter and First Half 2021 Financial Results and Hos…
|
English | 120.2 KB | ||
| 2021-08-05 16:04 |
Kamada to Announce Second Quarter and First Half 2021 Financial Results and Hos…
|
English | 36.0 KB | ||
| 2021-06-02 16:55 |
FDA Approval of KEDRAB® Label Update, Confirming Safety and
Effectiveness in …
|
English | 182.1 KB | ||
| 2021-06-02 16:55 |
FDA Approval of KEDRAB® Label Update, Confirming Safety and
Effectiveness in …
|
English | 36.0 KB | ||
| 2021-05-12 16:06 |
Kamada Reports First Quarter 2021 Financial Results
|
English | 261.5 KB | ||
| 2021-05-12 16:06 |
Kamada Reports First Quarter 2021 Financial Results
|
English | 36.0 KB | ||
| 2021-05-05 16:03 |
Kamada to Announce First Quarter Ended March 31, 2021 Financial Results and Hos…
|
English | 119.5 KB | ||
| 2021-05-05 16:03 |
Kamada to Announce First Quarter Ended March 31, 2021 Financial Results and Hos…
|
English | 36.1 KB | ||
| 2021-04-07 16:01 |
Announces Amendment to GLASSIA® License Agreement with Takeda
|
English | 170.9 KB |
Automate Your Workflow. Get a real-time feed of all Kamada Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kamada Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kamada Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
